(Q67494224)
Statements
Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients (English)
P. Reusser
J. G. Gambertoglio
K. Lilleby
1 September 1992
scientific article published on 01 September 1992